Study finds no evidence that cannabidiol (CBD) reduces the negative effects of cannabis.
Cannabidiol treatment helped reduce anxiety severity by, on average, 42.6% in young adults with treatment-resistant anxiety, a new study reports.
New findings reveal exercise increases levels of endocannabinoids in the body. The findings may explain some of the beneficial effects of exercise on the brain and body.
Scientists have identified three acidic cannabinoids in cannabis that reduces seizure activity in mouse models of Dravet syndrome.
Cannabis terpenes, the part of the plant which provides aroma and flavor, may provide therapeutic benefits in controlling pain, a new study reports.
Study reveals high-potency cannabis does not impact decision-making performance but does affect memory in relation to free recall, source memory, and false memories.
A newly developed cannabidiol capsule can be absorbed by the body faster and penetrate the brain more quickly in mouse models of neurological disorders such as Alzheimer's disease, multiple sclerosis and TBI.
A new study in Zebrafish reveals exposure to compounds found in cannabis during the early stages of development was linked to a significant drop in neural activity later in life.
A two-week course of CBD helps normalize and restore the function of two proteins associated with reducing amyloid-beta accumulation in mouse models of familial Alzheimer's disease. CBD also reduces levels of IL-6, an immune protein associated with inflammation in Alzheimer's patients.